Lindome, Sweden

Karl Thomas Antonsson

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 105(Granted Patents)


Company Filing History:


Years Active: 1997-2006

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Karl Thomas Antonsson

Introduction

Karl Thomas Antonsson is a notable inventor based in Lindome, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide derivatives and thrombin inhibitors. With a total of 7 patents to his name, Antonsson's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Antonsson has developed a pharmaceutical preparation that contains an effective amount of acetylsalicylic acid along with a compound of Formula I.A—A—NH—(CH)—B. Additionally, he has invented new competitive tripeptide inhibitors of trypsin-like serine proteases. These compounds are designed for use as thrombin inhibitors, anticoagulants, and anti-inflammatory agents, providing new avenues for the prophylaxis and treatment of related diseases.

Career Highlights

Throughout his career, Antonsson has worked with prominent companies in the pharmaceutical industry, including Astra Aktiebolag and Aktiebolaget Astra. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in his field.

Collaborations

Antonsson has collaborated with several talented individuals, including Ruth Elvy Bylund and Nils David Gustafsson. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Karl Thomas Antonsson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…